6Q7N image
Entry Detail
PDB ID:
6Q7N
Keywords:
Title:
Crystal structure of BH32 alkylated with the mechanistic inhibitor 2-bromoacetophenone
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2018-12-13
Release Date:
2019-06-05
Method Details:
Experimental Method:
Resolution:
2.02 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:BH32
Chain IDs:A
Chain Length:242
Number of Molecules:1
Biological Source:Pyrococcus horikoshii
Ligand Molecules
Primary Citation
Design and evolution of an enzyme with a non-canonical organocatalytic mechanism.
Nature 570 219 223 (2019)
PMID: 31132786 DOI: 10.1038/s41586-019-1262-8

Abstact

The combination of computational design and laboratory evolution is a powerful and potentially versatile strategy for the development of enzymes with new functions1-4. However, the limited functionality presented by the genetic code restricts the range of catalytic mechanisms that are accessible in designed active sites. Inspired by mechanistic strategies from small-molecule organocatalysis5, here we report the generation of a hydrolytic enzyme that uses Nδ-methylhistidine as a non-canonical catalytic nucleophile. Histidine methylation is essential for catalytic function because it prevents the formation of unreactive acyl-enzyme intermediates, which has been a long-standing challenge when using canonical nucleophiles in enzyme design6-10. Enzyme performance was optimized using directed evolution protocols adapted to an expanded genetic code, affording a biocatalyst capable of accelerating ester hydrolysis with greater than 9,000-fold increased efficiency over free Nδ-methylhistidine in solution. Crystallographic snapshots along the evolutionary trajectory highlight the catalytic devices that are responsible for this increase in efficiency. Nδ-methylhistidine can be considered to be a genetically encodable surrogate of the widely employed nucleophilic catalyst dimethylaminopyridine11, and its use will create opportunities to design and engineer enzymes for a wealth of valuable chemical transformations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures